Indonesia grants emergency use authorisation to Sinovac's COVID-19 vaccine
- Country:
- Indonesia
Indonesia's food and drug agency on Monday granted emergency use approval to a COVID-19 vaccine developed by China's Sinovac Biotech, as it became the first country outside China to give the regulatory greenlight to the vaccine.
Interim data from a late-stage human test in Indonesia showed the shot was 65.3% effective, Penny K. Lukito, who heads the country's food and drugs authority BPOM said.
ALSO READ
-
More Than Shorter Commute: How Compact Cities Can Help Migrant Workers Find Jobs
-
ADB Backs Indonesia With $650 Million to Expand Markets and Safer Digital Finance
-
ILO Report Reveals How to Bring Social Security Within Reach of Informal Workers
-
Indonesian Employers Seek a Stronger Voice in OECD Reforms on Jobs, Skills and Business
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
Google News